The same results were observed when wildtype GAMs (CD45+ CD11b+) were isolated from B6 host gliomas and compared to corresponding cells (CD45+ CD11b+ GAMs) from S100a4−/− host gliomas (p = 0.0004, Fig. 7c). This evidence concerns the gene S100A4 and central nervous system cancer.